12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga·02/13/2026 21:06:00
Listen to the news
Gainers
- CytoMed Therapeutics (NASDAQ:GDTC) shares moved upwards by 6.9% to $1.08 during Friday's after-market session. The market value of their outstanding shares is at $11.1 million.
- Akari Therapeutics (NASDAQ:AKTX) stock moved upwards by 6.26% to $0.25. The company's market cap stands at $8.5 million.
- Psyence Biomedical (NASDAQ:PBM) stock increased by 5.17% to $3.25. The market value of their outstanding shares is at $2.8 million.
- TScan Therapeutics (NASDAQ:TCRX) stock rose 5.13% to $0.98. The market value of their outstanding shares is at $53.0 million.
- Beyond Air (NASDAQ:XAIR) stock moved upwards by 4.76% to $1.1. The company's market cap stands at $8.7 million. As per the press release, Q3 earnings came out today.
- Polyrizon (NASDAQ:PLRZ) stock increased by 4.47% to $14.47. The market value of their outstanding shares is at $14.5 million.
Losers
- BioRestorative Therapies (NASDAQ:BRTX) shares declined by 8.8% to $0.26 during Friday's after-market session. The company's market cap stands at $2.1 million.
- AIM ImmunoTech (AMEX:AIM) stock decreased by 8.01% to $1.15. The company's market cap stands at $2.5 million.
- OKYO Pharma (NASDAQ:OKYO) shares declined by 8.0% to $1.61. The market value of their outstanding shares is at $88.0 million.
- Catheter Precision (AMEX:VTAK) shares decreased by 7.0% to $1.33. The company's market cap stands at $2.2 million.
- Quince Therapeutics (NASDAQ:QNCX) shares decreased by 3.91% to $0.19. The company's market cap stands at $12.5 million.
- SCWorx (NASDAQ:WORX) stock declined by 3.36% to $0.27. The company's market cap stands at $3.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.